
美喜劇演員德椎克.弗林涉嫌走私搖頭丸遭日逮捕
35歲美國喜劇演員德椎克.弗林(Dedrick Flynn)從台灣轉機赴日沖繩演出,卻在入境時遭海關查獲其護牙套盒內藏有0.73克搖頭丸(MDMA),當場被依違反《麻醉藥品取締法》逮捕,演出行程全取消,並已遭移送起訴。

35歲美國喜劇演員德椎克.弗林(Dedrick Flynn)從台灣轉機赴日沖繩演出,卻在入境時遭海關查獲其護牙套盒內藏有0.73克搖頭丸(MDMA),當場被依違反《麻醉藥品取締法》逮捕,演出行程全取消,並已遭移送起訴。

Australia is manufacturing MDMA and psilocybin for therapeutic use, with companies like Breathe Life Sciences producing these drugs for patients with PTSD and treatment-resistant depression. While early results are promising, experts urge caution due to costs and potential side effects.

Australia is pioneering psychedelic medicine, with licensed facilities manufacturing MDMA for PTSD and psilocybin for depression. Patients like Jess Yugovich report life-changing therapeutic benefits, though experts caution about costs and suitability, emphasizing the distinction between regulated medical use and illicit street drugs.

President Donald Trump signed an executive order on Saturday aimed at accelerating psychedelics research, directing agencies to expand clinical trials and Right to Try access for psilocybin, MDMA and ibogaine. The order leaves drug scheduling unchanged and comes amid stalled cannabis rescheduling efforts, raising questions about whether psychedelics will face similar federal delays. Psychedelic stocks rallied significantly following the announcement, with AtaiBeckley jumping roughly 25%.